Myriad Genetics Announces First Quarter Fiscal 2006 Financial Results Conference Call; Wednesday, October 26, 2005 at 10:30 a.m. ET

Salt Lake City, October 19, 2005 – Myriad Genetics, Inc. (Nasdaq: MYGN) has arranged a conference call with the management team to provide a company update. Peter Meldrum, President and Chief Executive Officer will host the call along with Jay Moyes, Chief Financial Officer, Gregory Critchfield, M.D., President of Myriad Genetic Laboratories, Inc. and Adrian Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.

DATE: October 26, 2005
TIME: 10:30 am ET
DOMESTIC DIAL-IN: (888) 589-2820
INTERNATIONAL DIAL-IN: (706) 634-2173

(Please dial in approximately 10 minutes before
the call is scheduled to begin)

A press release will be issued at 6:30 am ET on October 26, 2005.

Replay of the call will be available from two hours after the call
through November 2nd by dialing (800) 642-1687 or (706) 645-9291, and
entering conference ID number 1646218.

A live audio Webcast will be available at: www.myriad.com

This call is being webcast by Thomson/CCBN and is also being distributed though the Thomson/StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.fulldisclosure.com, Thomson/CCBN's individual investor portal. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).